Francisco-Javier González-Barcala
Francisco-Javier González-Barcala is an expert in Pulmonology at Complejo Hospitalario Universitario de Santiago (Spain). As of September 2026, ScienceLeadR ranks Francisco-Javier González-Barcala in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Francisco-Javier González-Barcala has authored 251 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 796 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Immunology - Pharmacy - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 251
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Defining lung function in asthma remission: Results of an international Delphi study. PMID 42740613 — lung, respiratory tract diseases, work, asthma | Pulmonology | 2026 | 1 |
| Mepolizumab Modifies Blood Eosinophil Proteome and Transcriptome in Severe Eosinophilic Asthma. PMID 42655930 — genes, gene expression profiling, blood, hypersensitivity, transcriptome, eosinophils, biomarkers, proteomics, therapeutics, asthma, proteome, biological therapy | Allergy | 2026 | 0 |
| Specialized Asthma Care Units in Spain: Limited Awareness; Strong Support. PMID 42125406 — asthma | Open Respir Arch | 2026 | 0 |
| Proteomics and Silica Dust: A Call to Reinforce Occupational History-taking. PMID 41947798 — dust, proteomics, history | Open Respir Arch | 2026 | 0 |
| The asthma-anxiety connection: friends or foes? PMID 41924916 — quality of life, prevalence, asthma | J Asthma | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control NCT06286007 — respiratory syncytial viruses, serology, whooping cough, signs and symptoms, viruses, prevalence, asthma, cough, infections, virus diseases, respiratory syncytial virus infections | N/A | Recruiting | 2023 |
| Follow up of Spanish Prospective Asthma and Nasal Polyposis Registry NCT06163807 — registries, polyps, eosinophils, biomarkers, therapeutics, asthma, nasal polyps, biological products, anti-asthmatic agents | N/A | Recruiting | 2025 |
| Effect of Mepolizumab on Severe Eosinophilic Asthma NCT04641741 — research design, flow cytometry, genes, serum, transcriptome, phenotype, eosinophils, rna, messenger, biomarkers, proteomics, therapeutics, asthma, proteome, eosinophilia, pulmonary eosinophilia | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map